financetom
Business
financetom
/
Business
/
Singapore bank UOB's Q4 profit beats forecasts, unveils $2.2 billion capital return
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Singapore bank UOB's Q4 profit beats forecasts, unveils $2.2 billion capital return
Feb 18, 2025 4:54 PM

By Yantoultra Ngui

SINGAPORE (Reuters) - Singapore's United Overseas Bank, or UOB, maintained its guidance for 2025 after posting on Wednesday a 9% rise in fourth-quarter net profit that beat expectations and announcing a S$3 billion ($2.24 billion) package to return surplus capital.

"Our long-term investments in regional platforms and capabilities are paying off, and we expect continued revenue growth this year," UOB CEO Wee Ee Cheong said in a statement.

UOB, Singapore's third-biggest bank, said October-December net profit climbed to S$1.52 billion ($1.13 billion) from S$1.40 billion a year earlier on the back of higher net interest income supported by loan growth.

This beat the mean estimate of almost S$1.46 billion from four analysts polled by LSEG.

UOB, which is also Southeast Asia's third-largest bank by assets, expected its 2025 cost-to-income ratio to be around 42%, the top end of the 41% to 42% range it had projected in November.

Other than that, the bank kept its outlook for 2025, according to Wee's presentation slides accompanying the fourth-quarter earnings.

UOB's results followed that of larger peer DBS Group, which last week posted a 10% year-on-year jump in fourth-quarter net profit that met expectations and announced a dividend capital return plan, sending shares to a record high.

Singaporean banks were forecast to post stronger profits for the fourth quarter, but growth could take a hit this year as U.S. President Donald Trump's trade tariffs and other policies threaten to undermine the global economy, analysts said.

Alongside its results, UOB announced a capital return package to distribute surplus capital over the next three years. That includes a special dividend of 50 Singapore cents a share in 2025 and a S$2 billion share buyback programme.

It declared a final dividend of 92 Singapore cents per share for 2024, versus the 85 Singapore cents announced during the same quarter a year ago for 2023.

Net interest margin, a key gauge of profitability, narrowed slightly to 2.00% in the fourth quarter from 2.02% in the same period a year earlier.

Rival Oversea-Chinese Banking Corporation is scheduled to report its financial results on February 26.

($1 = 1.3420 Singapore dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Mar 17, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Farmers National Company Acquires Peoples Bank and Trust Farm Management Business
Farmers National Company Acquires Peoples Bank and Trust Farm Management Business
Mar 17, 2026
OMAHA, Neb., March 17, 2026 /PRNewswire/ -- Farmers National Company is pleased to announce the acquisition of the Farm Management business of Peoples Bank and Trust, headquartered in McPherson, Kansas. The acquisition includes over 20,000 acres and brings Farmers National Company's total in Kansas to over 400,000 managed acres. This acquisition reflects a shared commitment to providing landowners with experienced,...
Pulse Biosciences to Prioritize Cardiac Catheter Program After Positive AFib Study Results
Pulse Biosciences to Prioritize Cardiac Catheter Program After Positive AFib Study Results
Mar 17, 2026
07:46 AM EDT, 03/17/2026 (MT Newswires) -- Pulse Biosciences ( PLSE ) said Tuesday it will focus more resources on developing its nPulse cardiac catheter ablation system following encouraging results from a European study in patients with atrial fibrillation. The company said data from more than 150 patients showed strong results, including high success rates and low complication levels. The...
BRIEF-Nofar Usa Completes 1Gw Solar Asset Acquisition From Pine Gate Renewables
BRIEF-Nofar Usa Completes 1Gw Solar Asset Acquisition From Pine Gate Renewables
Mar 17, 2026
March 17 (Reuters) - OY Nofar Energy Ltd: * NOFAR USA COMPLETES 1GW SOLAR ASSET ACQUISITION FROM PINE GATE RENEWABLES Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved